OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-κB pathwayMohamed Jalloul Nsaibia, Patrick Mathieu, Marie‐Chloé Boulanger et al.|Cardiovascular Research|2017Cited by 94
DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve diseaseGhada Mkannez, Patrick Mathieu, Luigi Bouchard et al.|Cardiovascular Research|2018Cited by 40
Enhancer-mediated enrichment of interacting JMJD3–DDX21 to ENPP2 locus prevents R-loop formation and promotes transcriptionDéborah Argaud, Patrick Mathieu, Marie‐Chloé Boulanger et al.|Nucleic Acids Research|2019Cited by 36
Genome-wide chromatin contacts of super-enhancer-associated lncRNA identify LINC01013 as a regulator of fibrosis in the aortic valveArnaud Chignon, Patrick Mathieu, Déborah Argaud et al.|PLoS Genetics|2022Cited by 23
Enhancer-associated aortic valve stenosis risk locus 1p21.2 alters NFATC2 binding site and promotes fibrogenesisArnaud Chignon, Patrick Mathieu, Mickaël Rosa et al.|iScience|2021Cited by 20